Category
Blog
-
2023
-
Avidity Biosciences Gets Fast Track for Facioscapulohumeral Muscular Dystrophy
-
National Institutes of Health grant to fund Alzheimer’s research
-
NICE Recommends Vutrisiran for Transthyretin-Related Amyloidosis
-
Merck Finds Causes of Nitrosamine in Diabetes Drugs
-
US FDA clears Transcenta’s IND for Rett syndrome treatment
-
Syros Gets Fast Track Status for Higher-Risk Myelodysplastic Syndrome Candidate
-
Cassava Claims Phase 2 Win for Its Alzheimer’s Candidate
-
FDA Approves Stemline’s Orserdu for Several Forms of Breast Cancer
-
FDA Grants Accelerated Approval to Eli Lilly’s Jaypirca in Mantle Cell Lymphoma
-
Roche, Boehringer tap biosensor firms for patient studies